PRM21 - MODELLING SURVIVAL OF PATIENTS WITH COMPLETELY RESECTED ADVANCED MELANOMA WITH ADJUVANT TREATMENT OF NIVOLUMAB VERSUS OBSERVATION
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2145
https://www.valueinhealthjournal.com/article/S1098-3015(18)35447-0/fulltext
Title :
PRM21 - MODELLING SURVIVAL OF PATIENTS WITH COMPLETELY RESECTED ADVANCED MELANOMA WITH ADJUVANT TREATMENT OF NIVOLUMAB VERSUS OBSERVATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35447-0&doi=10.1016/j.jval.2018.09.2145
First page :
Section Title :
Open access? :
No
Section Order :
1491